Back to search
Lichen Plano-Pilaris
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Lichen Plano-Pilaris trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Lichen Plano-Pilaris trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study evaluates the safety, tolerability, and biomarker effects of twice-daily topical delgocitinib 2% cream in adults with lichen planopilaris (LPP) or ce…
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris
Lichen planopilaris (LPP) is a primary lymphocytic cicatricial alopecia characterized by progressive, permanent hair loss and scalp symptoms such as pruritus an…
Rationale Lichen planopilaris (LPP) is a prevalent form of cicatricial alopecia, predominantly affecting women and causing irreversible hair loss. Hydroxychloro…
Lichen planus (LP) is a common immune-mediated skin disease with a prevalence of 1-2% in the general population. It can present with a broad spectrum of clinica…
The purpose of this clinical research study is to learn more about the use of Deucravacitinib in the treatment of Lichen Planopilaris.